Dobutamine-induced hypoperfusion without transient wall motion abnormalities: less severe ischemia or less severe stress?
A Elhendy,
ML Geleijnse,
Roelandt JR,
RT van Domburg,
FJ TenCate,
JH Cornel,
AE Reijs,
GM el-Said,
and
PM Fioretti
Thoraxcenter, University Hospital Rotterdam, Dijkzigt, The Netherlands.
OBJECTIVES. This study sought to compare the clinical characteristics, hemodynamic response and severity of ischemia in patients with coronary artery disease and reversible perfusion defects on dobutamine 2-methoxy isobutyl isonitrile (MIBI) single-photon emission computed tomography (SPECT) with or without transient wall motion abnormalities. BACKGROUND. The occurrence of reversible perfusion defects without concomitant wall motion abnormalities in patients with coronary artery disease was attributed to less severe ischemia. However, little data are available to support this observation. METHODS. Fifty-four consecutive patients with significant coronary artery disease and reversible perfusion defects on dobutamine (up to 40 micrograms/kg body weight per min) MIBI SPECT were studied (mean [+/- SD] age 59 +/- 11 years; 38 men, 16 women). All patients underwent simultaneous echocardiography. The myocardium was divided into six matched segments, and ischemic perfusion score was quantitatively derived in myocardial segments with reversible defects. RESULTS. New or worsening wall motion abnormalities occurred in 40 patients (74%) (group A) and were absent in 14 (26%) (group B). There was no significant difference between the two groups with respect to age, previous myocardial infarction, number of abnormal coronary arteries (1.8 +/- 0.8 vs. 1.6 +/- 0.9), number of reversible perfusion defects (1.6 +/- 0.9 vs. 1.8 +/- 0.7) or ischemic perfusion score (412 +/- 750 vs. 526 +/- 553). Patients in group A had a higher prevalence of male gender (80% vs. 43%, p < 0.01), higher peak systolic blood pressure (147 +/- 30 vs. 127 +/- 31 mm Hg, p < 0.05), higher peak rate-pressure product (19,632 +/- 4,081 vs. 16,939 +/- 4,344, p < 0.01) and a higher prevalence of angina (53% vs. 14%) and ST segment depression (55% vs. 14%) than group B (p < 0.05 for both). CONCLUSIONS. In patients with coronary artery disease and ischemia on dobutamine MIBI SPECT, the absence of transient wall motion abnormalities is associated with a similar extent and severity of reversible perfusion defects, a lower stress rate-pressure product and a higher prevalence of female gender than patients with transient wall motion abnormalities. Mechanically silent ischemia should not be regarded as a marker of less severe ischemia on myocardial perfusion scintigraphy.
This article has been cited by other articles:

|
 |

|
 |
 
S. Dodla, F. Xie, M. Smith, E. O'Leary, and T. R. Porter
Real-time perfusion echocardiography during treadmill exercise and dobutamine stress testing
Heart,
February 1, 2010;
96(3):
220 - 225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V Bodi, J Sanchis, M P Lopez-Lereu, J Nunez, L Mainar, J V Monmeneu, V Ruiz, E Rumiz, O Husser, D Moratal, et al.
Prognostic and therapeutic implications of dipyridamole stress cardiovascular magnetic resonance on the basis of the ischaemic cascade
Heart,
January 1, 2009;
95(1):
49 - 55.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Xie, S. Dodla, E. O'Leary, and T. R. Porter
Detection of subendocardial ischemia in the left anterior descending coronary artery territory with real-time myocardial contrast echocardiography during dobutamine stress echocardiography.
J. Am. Coll. Cardiol. Img.,
May 1, 2008;
1(3):
271 - 278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Tsutsui, F. Xie, D. Cloutier, S. Kalvaitis, A. Elhendy, and T. R. Porter
Real-time dobutamine stress myocardial perfusion echocardiography predicts outcome in the elderly
Eur. Heart J.,
February 1, 2008;
29(3):
377 - 385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Elhendy, E. L. O'Leary, F. Xie, A. C. McGrain, J. R. Anderson, and T. R. Porter
Comparative accuracy of real-time myocardial contrast perfusion imaging and wall motion analysis during dobutamine stress echocardiography for the diagnosis of coronary artery disease
J. Am. Coll. Cardiol.,
December 7, 2004;
44(11):
2185 - 2191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Elhendy, W. Ginete, S. Shurmur, and T. R. Porter
Acute myocardial infarction after a negative dobutamine stress echocardiogram
Eur Heart J Cardiovasc Imaging,
December 1, 2004;
5(6):
469 - 471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Elhendy, J. J. Bax, and D. Poldermans
Dobutamine Stress Myocardial Perfusion Imaging in Coronary Artery Disease
J. Nucl. Med.,
December 1, 2002;
43(12):
1634 - 1646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lafitte, H. Matsugata, B. Peters, M. Togni, M. Strachan, O. L. Kwan, and A. N. DeMaria
Comparative Value of Dobutamine and Adenosine Stress in the Detection of Coronary Stenosis With Myocardial Contrast Echocardiography
Circulation,
June 5, 2001;
103(22):
2724 - 2730.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Porter, F. Xie, M. Silver, D. Kricsfeld, and E. O'Leary
Real-time perfusion imaging with low mechanical index pulse inversion Doppler imaging
J. Am. Coll. Cardiol.,
March 1, 2001;
37(3):
748 - 753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Elhendy, R T van Domburg, J J Bax, P R Nierop, M L Geleijnse, M M Ibrahim, and J R T C Roelandt
The functional significance of chronotropic incompetence during dobutamine stress test
Heart,
April 1, 1999;
81(4):
398 - 403.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J A S. Roman, I Vilacosta, J A Castillo, M J Rollan, M Hernandez, V Peral, I Garcimartin, M d. M. de la Torre, and F Fernandez-Aviles
Selection of the optimal stress test for the diagnosis of coronary artery disease
Heart,
October 1, 1998;
80(4):
370 - 376.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Elhendy, R. T. van Domburg, J. R. T. C. Roelandt, M. L. Geleijnse, M. M. Ibrahim, and P. M. Fioretti
Safety and Feasibility of Dobutamine-Atropine Stress Testing in Hypertensive Patients
Hypertension,
June 1, 1997;
29(6):
1232 - 1239.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Leong-Poi, S.-J. Rim, D. E. Le, N. G. Fisher, K. Wei, and S. Kaul
Perfusion Versus Function: The Ischemic Cascade in Demand Ischemia: Implications of Single-Vessel Versus Multivessel Stenosis
Circulation,
February 26, 2002;
105(8):
987 - 992.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|